FDA Approved: RIVASTIGMINE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved an original generic rivastigmine application from Mylan for treatment of dementia associated with Alzheimer's disease and Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

ORIG AP for RIVASTIGMINE (RIVASTIGMINE)